MX2014011473A - Procedimientos y composiciones de tratamiento de enfermedades vasculares arterioscleroticas. - Google Patents

Procedimientos y composiciones de tratamiento de enfermedades vasculares arterioscleroticas.

Info

Publication number
MX2014011473A
MX2014011473A MX2014011473A MX2014011473A MX2014011473A MX 2014011473 A MX2014011473 A MX 2014011473A MX 2014011473 A MX2014011473 A MX 2014011473A MX 2014011473 A MX2014011473 A MX 2014011473A MX 2014011473 A MX2014011473 A MX 2014011473A
Authority
MX
Mexico
Prior art keywords
methods
compositions
compound
vascular diseases
ldl
Prior art date
Application number
MX2014011473A
Other languages
English (en)
Inventor
Liu Sheng-Yung
Wen Wu-Che
Chen Chih-Ming
Original Assignee
Golden Biotechnology Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Golden Biotechnology Corp filed Critical Golden Biotechnology Corp
Publication of MX2014011473A publication Critical patent/MX2014011473A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/07—Basidiomycota, e.g. Cryptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/133—Amines having hydroxy groups, e.g. sphingosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/753—Unsaturated compounds containing a keto groups being part of a ring containing ether groups, groups, groups, or groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0031—Rectum, anus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

La presente invención proporciona procedimientos y composiciones para tratar enfermedades vasculares arterioscleróticas por compuestos de ciclohexenona.
MX2014011473A 2012-03-26 2013-03-26 Procedimientos y composiciones de tratamiento de enfermedades vasculares arterioscleroticas. MX2014011473A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261615794P 2012-03-26 2012-03-26
US201361789304P 2013-03-15 2013-03-15
PCT/US2013/033900 WO2013148701A1 (en) 2012-03-26 2013-03-26 Methods and compositions for treating arteriosclerotic vascular diseases

Publications (1)

Publication Number Publication Date
MX2014011473A true MX2014011473A (es) 2014-12-08

Family

ID=49261175

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2014011473A MX2014011473A (es) 2012-03-26 2013-03-26 Procedimientos y composiciones de tratamiento de enfermedades vasculares arterioscleroticas.

Country Status (11)

Country Link
US (1) US10905656B2 (es)
EP (1) EP2830640B1 (es)
JP (1) JP6234990B2 (es)
KR (1) KR20150002685A (es)
CN (1) CN104220083B (es)
AU (1) AU2013239861A1 (es)
BR (1) BR112014023809A2 (es)
CA (1) CA2867521A1 (es)
ES (1) ES2886345T3 (es)
MX (1) MX2014011473A (es)
WO (1) WO2013148701A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104968339B (zh) * 2012-11-21 2019-06-11 国鼎生物科技股份有限公司 用于治疗神经变性疾病的方法和组合物
CN107648282A (zh) * 2016-07-26 2018-02-02 北京大学 牛樟芝在防治心肌肥大及心肌纤维化中的应用
CN115607738B (zh) * 2022-10-31 2023-07-14 中国人民解放军陆军军医大学 基于仿生内皮细胞抗血栓功能的心血管植入物及其制备方法

Family Cites Families (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3598123A (en) 1969-04-01 1971-08-10 Alza Corp Bandage for administering drugs
US3598122A (en) 1969-04-01 1971-08-10 Alza Corp Bandage for administering drugs
US3993073A (en) 1969-04-01 1976-11-23 Alza Corporation Novel drug delivery device
US3710795A (en) 1970-09-29 1973-01-16 Alza Corp Drug-delivery device with stretched, rate-controlling membrane
US4069307A (en) 1970-10-01 1978-01-17 Alza Corporation Drug-delivery device comprising certain polymeric materials for controlled release of drug
US3731683A (en) 1971-06-04 1973-05-08 Alza Corp Bandage for the controlled metering of topical drugs to the skin
US3742951A (en) 1971-08-09 1973-07-03 Alza Corp Bandage for controlled release of vasodilators
US3996934A (en) 1971-08-09 1976-12-14 Alza Corporation Medical bandage
BE795384A (fr) 1972-02-14 1973-08-13 Ici Ltd Pansements
US3921636A (en) 1973-01-15 1975-11-25 Alza Corp Novel drug delivery device
US3993072A (en) 1974-08-28 1976-11-23 Alza Corporation Microporous drug delivery device
US3972995A (en) 1975-04-14 1976-08-03 American Home Products Corporation Dosage form
US4077407A (en) 1975-11-24 1978-03-07 Alza Corporation Osmotic devices having composite walls
US4031894A (en) 1975-12-08 1977-06-28 Alza Corporation Bandage for transdermally administering scopolamine to prevent nausea
US4031893A (en) 1976-05-14 1977-06-28 Survival Technology, Inc. Hypodermic injection device having means for varying the medicament capacity thereof
US4060084A (en) 1976-09-07 1977-11-29 Alza Corporation Method and therapeutic system for providing chemotherapy transdermally
US4201211A (en) 1977-07-12 1980-05-06 Alza Corporation Therapeutic system for administering clonidine transdermally
JPS5562012A (en) 1978-11-06 1980-05-10 Teijin Ltd Slow-releasing preparation
US4230105A (en) 1978-11-13 1980-10-28 Merck & Co., Inc. Transdermal delivery of drugs
US4291015A (en) 1979-08-14 1981-09-22 Key Pharmaceuticals, Inc. Polymeric diffusion matrix containing a vasodilator
US4476116A (en) 1982-12-10 1984-10-09 Syntex (U.S.A.) Inc. Polypeptides/chelating agent nasal compositions having enhanced peptide absorption
US5116817A (en) 1982-12-10 1992-05-26 Syntex (U.S.A.) Inc. LHRH preparations for intranasal administration
US5312325A (en) 1987-05-28 1994-05-17 Drug Delivery Systems Inc Pulsating transdermal drug delivery system
US5633009A (en) 1990-11-28 1997-05-27 Sano Corporation Transdermal administration of azapirones
US5540664A (en) 1993-05-27 1996-07-30 Washington Biotech Corporation Reloadable automatic or manual emergency injection system
US5358489A (en) 1993-05-27 1994-10-25 Washington Biotech Corporation Reloadable automatic or manual emergency injection system
US5695472A (en) 1993-05-27 1997-12-09 Washington Biotech Corporation Modular automatic or manual emergency medicine injection system
US5665378A (en) 1994-09-30 1997-09-09 Davis; Roosevelt Transdermal therapeutic formulation
US6929801B2 (en) 1996-02-19 2005-08-16 Acrux Dds Pty Ltd Transdermal delivery of antiparkinson agents
US6923983B2 (en) 1996-02-19 2005-08-02 Acrux Dds Pty Ltd Transdermal delivery of hormones
US6391452B1 (en) 1997-07-18 2002-05-21 Bayer Corporation Compositions for nasal drug delivery, methods of making same, and methods of removing residual solvent from pharmaceutical preparations
US5869090A (en) 1998-01-20 1999-02-09 Rosenbaum; Jerry Transdermal delivery of dehydroepiandrosterone
US6946144B1 (en) 1998-07-08 2005-09-20 Oryxe Transdermal delivery system
US7544189B2 (en) 2000-10-10 2009-06-09 Meridian Medical Technologies, Inc. Needle and hub assembly for automatic injector
TW200638867A (en) * 2005-05-06 2006-11-16 Golden Biotechnology Corp Incubation and application methods for the culture of antrodia camphorata
US7468932B2 (en) * 2005-05-13 2008-12-23 Pgs Americas, Inc. System for noise attenuation in marine seismic streamers
TW200829234A (en) * 2007-01-08 2008-07-16 Golden Biotechnology Corp Antrodia camphorata isophorone extract
CN101225066B (zh) * 2007-01-18 2010-09-22 国鼎生物科技股份有限公司 牛樟芝的环己烯酮萃取物
TWI394573B (zh) * 2007-06-14 2013-05-01 Golden Biotechnology Corp Application of Cynanchum auranthone Cyclohexenone Compounds in the Preparation of Drugs for Liver Protection
TWI394566B (zh) * 2009-09-09 2013-05-01 Golden Biotechnology Corp Used to inhibit the growth of ovarian cancer tumor cells of the cattle camphor cyclohexene ketone compounds
US8697086B2 (en) * 2010-01-19 2014-04-15 Chieh-Chou Yu Use of Antrodia camphorata for treating diseases

Also Published As

Publication number Publication date
CA2867521A1 (en) 2013-03-26
EP2830640A4 (en) 2016-03-30
JP6234990B2 (ja) 2017-11-22
ES2886345T3 (es) 2021-12-17
CN104220083B (zh) 2018-11-27
JP2015512407A (ja) 2015-04-27
AU2013239861A1 (en) 2014-09-25
KR20150002685A (ko) 2015-01-07
BR112014023809A2 (pt) 2017-07-18
US20150080477A1 (en) 2015-03-19
WO2013148701A8 (en) 2014-12-18
EP2830640A1 (en) 2015-02-04
WO2013148701A1 (en) 2013-10-03
CN104220083A (zh) 2014-12-17
EP2830640B1 (en) 2021-07-21
US10905656B2 (en) 2021-02-02

Similar Documents

Publication Publication Date Title
PH12019501131A1 (en) Composition for treating hyperlipidemia comprising oxytomodulin derivative
WO2012100229A3 (en) Compositions and methods for cardiovascular disease
CR20140256A (es) Inhibitor de cetp de oxazolidinona bicíclico fusionado
EA201400528A1 (ru) Пролекарство адреномедуллина на основе полиэтиленгликоля и его применение
MY195443A (en) Tissue Factor Pathway Inhibitor Antibodies and uses Thereof
WO2012118903A3 (en) Sclerostin and dkk-1 bispecific binding agents
MX2014014339A (es) Metodos y composiciones para modular la expresion de apolipoproteina (a).
UY34280A (es) Nuevos compuestos que tienen actividad inhibidora frente a la daminoacido oxidasa.
WO2013188417A3 (en) Treatment and prevention of cardiovascular disease and thrombosis
MX2014011473A (es) Procedimientos y composiciones de tratamiento de enfermedades vasculares arterioscleroticas.
CR11272A (es) Enzimas de aciltranferasa de lecitina-colesterol, modificadas
EA201100756A1 (ru) Способ лечения или профилактики тромбоза с использованием этексилата дабигатрана или его соли с улучшенным профилем безопасности по сравнению со стандартным лечением варфарином
MX2017014095A (es) Uso de cd24 para disminuir los niveles de colesterol de las lipoproteinas de baja densidad.
NZ715582A (en) Lectin-like oxidized ldl receptor 1 antibodies and methods of use
MX370253B (es) Composiciones de compuestos de jasmonato y métodos de uso de las mismas.
NZ729600A (en) Binding proteins specific for lox1 and uses thereof
NZ615578A (en) Pyridopyrazine derivatives and their use
CO2017002813A2 (es) Derivados estabilizados de adrenomedulina y uso de los mismos
IN2015KN00212A (es)
PH12015501099A1 (en) Synbiotic composition and use thereof
NZ611614A (en) Compositions and methods for treating amyloid plaque associated symptoms
CO6630197A2 (es) Nuevos procesos
MX355816B (es) Metodo para tratar los defectos de espacio oseo.
MX364626B (es) Péptidos miméticos.
UY34031A (es) Componente de éster aromático en la formulación de composiciones agroquímicas